Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2012
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115838 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same
05/10/2012US20120115837 Solid Preparation
05/10/2012US20120115832 TGR5 Modulators and Methods of Use Thereof
05/10/2012US20120115827 3-aminobenzamide compounds and vanilloid receptor subtype 1 (vr1) inhibitors
05/10/2012US20120115826 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor
05/10/2012US20120115824 Vitamin D Receptor Agonists and Uses Thereof
05/10/2012US20120115815 Compositions useful especially for treatment or prevention of metabolic syndrome
05/10/2012US20120115799 Pharmaceutical formulations
05/10/2012US20120115786 Agent for reducing risk in onset of disease ascribable to non-dipper circadian rhythm of blood pressure
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115229 Embryonic stem cells and neural progenitor cells derived therefrom
05/10/2012US20120114775 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
05/10/2012US20120114770 High amylose wheat
05/10/2012US20120114753 Multi-layer tablet comprising effervescent layer
05/10/2012US20120114745 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/10/2012US20120114744 Compositions and methods to treat muscular & cardiovascular disorders
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114732 Elastin stabilization of connective tissue
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114652 Anti-pai-1 antibodies and methods of use thereof
05/10/2012US20120114627 Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
05/10/2012US20120114622 Lactobacillus rhamnosus and weight control
05/10/2012US20120114598 IL-1alpha immunization induces autoantibodies protective against atherosclerosis
05/10/2012US20120114588 Ibat inhibitors for treatment of metabolic disorders and related conditions
05/10/2012US20120114577 Peptide Having Activity of Transforming Growth Factor and Production Method Therefor
05/10/2012US20120114565 Compounds modulators of vegf activity and uses thereof
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012DE102010048800A1 Chinoxalinderivate Quinoxaline derivatives
05/10/2012DE102010043380A1 Benzyl-substituierte Carbamate und ihre Verwendung Benzyl-substituted carbamates and their use
05/10/2012DE102010043379A1 Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung Substituted 6-fluoro-1H-pyrazolo [4,3-b] pyridines and their use
05/10/2012CA2816949A1 Methods of treatment using lipid compounds
05/10/2012CA2816671A1 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof
05/10/2012CA2816639A1 Benzyl-substituted carbamates and use thereof
05/10/2012CA2815611A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012CA2813671A1 Pharmaceutical combinations for the treatment of metabolic disorders
05/10/2012CA2811948A1 Methods for treatment of brain injury utilizing biologics
05/09/2012EP2450352A1 Prophylactic or therapeutic agent for cancer
05/09/2012EP2450350A1 3-Pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as HDL-cholesterol raising agents
05/09/2012EP2448953A1 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thatreof as a2ar agonists
05/09/2012EP2448945A1 Crystalline forms of prasugrel salts
05/09/2012EP2448933A1 Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
05/09/2012EP2448928A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
05/09/2012EP2448572A1 Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation
05/09/2012EP2448561A1 Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
05/09/2012EP2213292B1 Double-stranded oligonucleotides
05/09/2012EP1651646B1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i
05/09/2012EP1609798B1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
05/09/2012EP1501467B1 Heterocyclo inhibitors of potassium channel function
05/09/2012EP1423107B1 Fatty alcohol drug conjugates
05/09/2012EP1284963B1 Novel calcium receptor active molecules and method for preparing same
05/09/2012CN1931294B Chinese medicine composition for treating ischemic apoplexy and its preparation process
05/09/2012CN1861099B Snake oil soft capsule
05/09/2012CN102448949A Heterocyclic compound and hematopoietic stem cell amplifier
05/09/2012CN102448941A Substituted isoquinoline derivative
05/09/2012CN102448937A Aryl Substituted Carboxamide Derivatives As Calcium Or Sodium Channel Blockers
05/09/2012CN102448459A Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
05/09/2012CN102448456A Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
05/09/2012CN102448455A Use of flavonoids to increase the bioavailability of hesperetin
05/09/2012CN102443594A Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application
05/09/2012CN102443530A Ginseng wolfberry health promotion wine
05/09/2012CN102443027A Fructose glycosylation puerarin, preparation method and application thereof
05/09/2012CN102442995A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
05/09/2012CN102442970A Novel compounds as cannabinoid receptor ligands and uses thereof
05/09/2012CN102442918A Stable levocarnitine compound
05/09/2012CN102442237A Automobile cushion
05/09/2012CN102441177A Nano bubble carrier for small interfering ribonucleic acid (siRNA) transfer
05/09/2012CN102441156A Traditional Tibetan medicinal composition and preparation method thereof
05/09/2012CN102441150A Medicine composition for treating cardiac and pulmonary multi-viscera failure and preparation method thereof
05/09/2012CN102441134A Chinese herbal medicinal composition, preparation, and preparation method and application thereof
05/09/2012CN102441129A Traditional Chinese medicine for treating chronic pulmonary heart disease
05/09/2012CN102441125A Traditional Chinese medicine preparation for treating cerebral apoplexy sequelae
05/09/2012CN102441117A Traditional Chinese medicinal preparation for treating vascular headache
05/09/2012CN102441106A Traditional Chinese herbal composition for treating cardiovascular and cerebrovascular diseases
05/09/2012CN102441104A Traditional Chinese medicine composition used for treating viral myocarditis, and preparation method thereof
05/09/2012CN102441102A Method for measuring content of oligosaccharide components in medicinal materials
05/09/2012CN102441101A Method for measuring total lignin content in qi-tonifying Fumai for injection
05/09/2012CN102441096A Novel blood stasis elimination and collaterals dredging compound pill and preparation method thereof
05/09/2012CN102441093A Medicine for lowering transplant renal arterial resistance index
05/09/2012CN102441051A Extraction process for flavedo flavone
05/09/2012CN102441040A Preparation method of cistanche deserticola phenylethanoid glycosides
05/09/2012CN102441019A Chinese medicinal chrysanthemum buccal tablet
05/09/2012CN102440995A Chemical activity of natural compound, and use of natural compound
05/09/2012CN102440993A Amlodipine benazepril tablet and preparation method thereof
05/09/2012CN102440981A Application of natural resveratrol dimer Pallidol-like compound in pharmacy
05/09/2012CN102440972A Gliclazide tablet (II) and preparation method thereof
05/09/2012CN102440946A Preparation method of dyclonine ointment
05/09/2012CN102440673A Radiation-proof health-care drape
05/09/2012CN102440477A Drug insole
05/09/2012CN102114003B Sustained-release pellet of hydroxysafflor yellow A as well as preparation method and applications thereof
05/09/2012CN102100725B Preparation technology of extracting total alkaloid extraction from Gansu whin
05/09/2012CN102091291B Chinese medicine composition for treating cerebral arteriosclerosis
05/09/2012CN102028751B Chinese medicinal composition serving as phytoestrogen and application thereof
05/09/2012CN101991665B Composition for treating myocardial diseases, femoral head necrosis and tumor and preparation process thereof
05/09/2012CN101974015B Ester compound and preparation method and application thereof
05/09/2012CN101961192B Chinese medicinal health-care pillow
1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 1595